Literature DB >> 19856276

A bivariate survival model with compound Poisson frailty.

A Wienke1, S Ripatti, J Palmgren, A Yashin.   

Abstract

A correlated frailty model is suggested for analysis of bivariate time-to-event data. The model is an extension of the correlated power variance function (PVF) frailty model (correlated three-parameter frailty model) (J. Epidemiol. Biostat. 1999; 4:53-60). It is based on a bivariate extension of the compound Poisson frailty model in univariate survival analysis (Ann. Appl. Probab. 1992; 4:951-972). It allows for a non-susceptible fraction (of zero frailty) in the population, overcoming the common assumption in survival analysis that all individuals are susceptible to the event under study. The model contains the correlated gamma frailty model and the correlated inverse Gaussian frailty model as special cases. A maximum likelihood estimation procedure for the parameters is presented and its properties are studied in a small simulation study. This model is applied to breast cancer incidence data of Swedish twins. The proportion of women susceptible to breast cancer is estimated to be 15 per cent.

Entities:  

Mesh:

Year:  2010        PMID: 19856276      PMCID: PMC4362709          DOI: 10.1002/sim.3749

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  25 in total

1.  Estimation of multivariate frailty models using penalized partial likelihood.

Authors:  S Ripatti; J Palmgren
Journal:  Biometrics       Date:  2000-12       Impact factor: 2.571

2.  A bivariate cure-mixture approach for modeling familial association in diseases.

Authors:  N Chatterjee; J Shih
Journal:  Biometrics       Date:  2001-09       Impact factor: 2.571

3.  A bivariate frailty model with a cure fraction for modeling familial correlations in diseases.

Authors:  Andreas Wienke; Paul Lichtenstein; Anatoli I Yashin
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

4.  A distribution for multivariate frailty based on the compound Poisson distribution with random scale.

Authors:  Tron Anders Moger; Odd O Aalen
Journal:  Lifetime Data Anal       Date:  2005-03       Impact factor: 1.588

Review 5.  Breast cancer (1)

Authors:  J R Harris; M E Lippman; U Veronesi; W Willett
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

6.  Generalizations and applications of frailty models for survival and event data.

Authors:  A Pickles; R Crouchley
Journal:  Stat Methods Med Res       Date:  1994       Impact factor: 3.021

7.  A concordance test for independence in the presence of censoring.

Authors:  D Oakes
Journal:  Biometrics       Date:  1982-06       Impact factor: 2.571

Review 8.  Genetic testing for cancer risk.

Authors:  B Ponder
Journal:  Science       Date:  1997-11-07       Impact factor: 47.728

9.  Analysis of testicular cancer data using a frailty model with familial dependence.

Authors:  Tron A Moger; Odd O Aalen; Ketil Heimdal; Håkon K Gjessing
Journal:  Stat Med       Date:  2004-02-28       Impact factor: 2.373

10.  Frailty modelling of testicular cancer incidence using Scandinavian data.

Authors:  Tron A Moger; Odd O Aalen; Tarje O Halvorsen; Hans H Storm; Steinar Tretli
Journal:  Biostatistics       Date:  2004-01       Impact factor: 5.899

View more
  3 in total

1.  Modeling the rate of HIV testing from repeated binary data amidst potential never-testers.

Authors:  John D Rice; Brent A Johnson; Robert L Strawderman
Journal:  Biostatistics       Date:  2019-04-01       Impact factor: 5.899

2.  Compound Poisson frailty model with a gamma process prior for the baseline hazard: accounting for a cured fraction.

Authors:  Maryam Rahmati; Parisa Rezanejad Asl; Javad Mikaeli; Hojjat Zeraati; Aliakbar Rasekhi
Journal:  J Appl Stat       Date:  2021-07-05       Impact factor: 1.416

3.  Modelling recurrent events: comparison of statistical models with continuous and discontinuous risk intervals on recurrent malaria episodes data.

Authors:  Issaka Sagara; Roch Giorgi; Ogobara K Doumbo; Renaud Piarroux; Jean Gaudart
Journal:  Malar J       Date:  2014-07-29       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.